Genomic DNA is exposed to a constant insult from sources that are both endogenous and exogenous to the cell. REV1 protein, a eukaryotic member of Y family of DNA polymerases, is involved in the tolerance to such DNA damages by providing a translesion DNA synthesis. Here, we examined possible association between REV1 polymorphisms and breast cancer risk in Thai women. Five single nucleotide polymorphisms (SNPs) REV1 (rs3792152, rs3087395, rs3792137, rs959929, rs3087386) were genotyped. The study population consists of 570 patients with histopathologically conˆrmed breast cancer and 497 controls. Association of genotypes with breast cancer risk was evaluated using multivariate logistic regression to estimate odds ratios (OR) and their 95z conˆdence intervals (95zCI). Our results revealed that the heterozygote carrier of REV1 SNP (rs3087395) was associated with breast cancer risk with OR＝1.59 (95 zCI: 1.11-2.29). In addition, an increased risk was observed for homozygotes at the REV1 SNP (rs 959929) with the OR＝1.52 (95zCI: 1.01-2.29). A stratiˆed analysis suggested that the association between the REV1 SNPs and breast cancer is diŠerent by the menopausal status. The present results suggest that REV1 polymorphisms are likely to play a modifying role in the individual susceptibility to breast cancer among Thai women.
Genomic DNA is exposed to a constant insult from sources that are both endogenous and exogenous to the cell. REV1 protein, a eukaryotic member of Y family of DNA polymerases, is involved in the tolerance to such DNA damages by providing a translesion DNA synthesis. Here, we examined possible association between REV1 polymorphisms and breast cancer risk in Thai women. Five single nucleotide polymorphisms (SNPs) REV1 (rs3792152, rs3087395, rs3792137, rs959929, rs3087386) were genotyped. The study population consists of 570 patients with histopathologically conˆrmed breast cancer and 497 controls. Association of genotypes with breast cancer risk was evaluated using multivariate logistic regression to estimate odds ratios (OR) and their 95z conˆdence intervals (95zCI). Our results revealed that the heterozygote carrier of REV1 SNP (rs3087395) was associated with breast cancer risk with OR＝1.59 (95 zCI: 1.11-2.29). In addition, an increased risk was observed for homozygotes at the REV1 SNP (rs 959929)Introduction A critical step in the malignant transformation of cells in the carcinogenesis process is the induction of mutations in the DNA by genotoxic agents. DNA damage-induced mutation arises in a consequence of the error-prone activity of specialize DNA polymerases to synthesize across base lesions that have arrested DNA replication, a process known as translesion synthesis (TLS). TLS is performed by relatively new category of accessory DNA polymerases. Polymerase h (Pol h), Pol i, Pol k and REV1 in the Y-family (1) and Pol z in the B-family (2,3) are responsible for most TLS in mammalian cells. REV1 is a deoxycytidyltransferase that preferentially incorporates deoxycytidines opposite several damaged template bases and abasic sites (4, 5) . REV1 is also necessary for the bypass of some types of ultraviolet (UV) photo adducts in vivo (6) , and the protein is an important structural component for TLS in general (7, 8) . REV1 contains a BRCA1 C-terminal (BRCT) domain in the N terminus, a central polymerase domain, and a Y-family polymerase contacting region in the C terminus. The BRCT domain serves as a scaŠold that mediates protein-protein interactions. Deletion of the BRCT domain of REV1 in ES cells resulted in increased sensitivity to DNA-damaging agents, indicating that this domain is involved in tolerance to DNA damage (9) . Single nucleotide polymorphisms (SNPs) can cause structural alterations in the repair enzyme and therefore changes in the susceptibility to cancer (10, 11) . Genetic variations of REV1 gene may modify breast cancer risk.
We previously reported a number of SNPs in base excision and double-strand breaks repair pathways and breast cancer risk (12, 13) . We also reported the genetic polymorphisms in estrogen, alcohol and folate metabolism enzyme (14, 15) . In this study, we present data on the association between REV1 polymorphisms and breast cancer risk in a case-control study of Thai women.
Materials and Methods
Study population: Ascertainment of the cases and controls and their demographic characteristics were described previously (14, 15) . Brie‰y, cases were all new incident breast cancer patients histologically diagnosed at the National Cancer Institute in Bangkok and at the hospital in Khon Kaen province of North Eastern of ). Controls were randomly selected from healthy women who visited patients admitted to the same hospitals for diseases other than breast or ovarian cancer. Control subjects were recruited during the same study period as the case ascertainment. The participation rate among visitors who were asked to participate was 98.9z (642/649). Informed consent was obtained from all participants and a structured questionnaire was administered by trained interviewers to collect information on demographic and anthropometric data, reproductive and medical history, residential history, physical activity and occupation as well as diet (Table 1) . Lifestyle exposure parameters were reported as follows: tobacco smoking: less than or equal to 6 months of smoking in life, or if she smokes longer than 6 months, the sum of cigarettes smoked is less than or equal 50 per 6 months (non-smoker) versus more than 50 cigarettes over a 6 mon period (smoker); involuntary tobacco smoking: less versus more than or equal to 1 h of exposure per day; alcohol consumption: less versus more than or equal to once a week for at least 6 months. In addition to the questionnaire, 570 cases and 497 controls agreed to donate approximately 7 mL of blood to the genotype analysis, resulting in a participation rate of 95.0z (cases) and 77.4z (controls). The study was approved by the ethical review committee for research in human subjects, Ministry of Public Health, Thailand and by the ethics committee of National Cancer Center, Japan.
Genotyping analysis: Genomic DNA was isolated from buŠy coats using a QIAmp DNA blood kit (Qiagen, Hilden, Germany). DNA concentrations were measured by PicoGreen dsDNA qualiˆcation kits (Molecular Probes, Leiden, The Netherlands). Five SNPs were selected from the dbSNP database considering the reasonable coverage of the REV1 gene region and r2measures) showed an extensive block with a low recombination rate for the HapMap JPT＋CHB subjects. The map was assembled by the UCSC Genome Browser using the NCBI 36/hg18 assembly data.
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REV1 Polymorphisms and Breast Cancer Risk ( Fig. 1) , minor allele frequencies in the HapMap JPT＋ CHB population and probe availability for the TaqMan5? nuclease assay using the ABI PRISM 7900 HT Sequence Detection System (Applied Biosystems LLC, Foster, California, USA). Oligonucleotide primers and the dual labeled allele speciˆc probes were designed by ABI. PCR were performed in 384-well plates with each plate containing four control samples. A set of three 384-well plates were prepared to accommodate 570 cases and 497 control subjects and used for genotyping. Genomic DNA (5 ng) was ampliˆed in a total volume of 5 mL in the presence of 100 mM of each of the dNTPs, 3 pmols of each of appropriate primers, 2 pmols of each of the corresponding dual labeled probes, and 0.025 units of Taq DNA polymerase. PCR cycling consisted of 40 cycles at 949 C for 15 sec, 55-609 C for 15 sec and 729 C for 15 sec. The results of 5z blindly repeated samples were at least 99z concordant each other. Genotyping success rate for individual polymorphisms averaged 95z.
Statistical analyses: Hardy-Weinberg equilibrium (HWE) test was used as one of the measures for a quality control for genotyping, and allele and genotype frequencies were calculated. The multivariate logistic regression analyses were applied to evaluate diŠerences in genotype distributions, and the odds ratios (OR) and their 95z conˆdence intervals (CI) were calculated after adjustment for the following covariates: age, body mass index (BMI), smoking, pregnancy & breast feeding, family history of breast cancer in theˆrst-degree relatives, education and menopausal status. Cochran-Armitage trend test was also performed with the same adjustment factors. The Mantel-Haenszel test was used to evaluate diŠerences in allele frequencies between stratiˆed groups. All statistical analyses were carried out using the Statistical Analysis System (SAS) software Version 9.2 (SAS Institute Inc, Cary, NC), and partially the R suite (http://www.r-project.org/). Table 1 presents the distribution of selected characteristics for cases and controls (14, 15) . The mean age of controls (43.2±12.4 years) was signiˆcantly lower ( pº0.01) than that of breast cancer patients (46.0± 10.6 years). Pregnancy, menopausal status, breast feeding, BMI, involuntary tobacco smoking, family history of breast cancer, and education were diŠerent between cases and controls. However, no signiˆcant diŠerences were found for oral contraceptive use, smoking, and alcohol consumption. Genotype frequencies were consistent with those predicted by the Hardy-Weinberg equilibrium model in both cases and controls (Table 2 ). Allele frequencies of each SNP in diŠerent ethnic group could be found in the website www.genecards.org. Logistic regression analysis revealed that compared with REV1 AA genotype (rs3087395), women carrying heterozygous GA genotype had signiˆcantly increased risk of breast cancer, while the MAF was too low to evaluate homozygous GG genotype for the SNP (Table 3) . Homozygotes of minor alleles of rs959929 and those of rs3087386 (Phe257Ser) showed an increased risk of breast cancer. In addition to the genotype-speciˆc odds ratio, an allele-number eŠect was evaluated by the Cochran-Armitage trend test, which showed a marginally signiˆcant association for rs3792137. Considering the substantial linkage disequilibrium of the entire REV1 gene region (Fig. 1) , the overall data on Table 3 suggest an association between the REV1 polymorphisms and breast cancer risk.
Results
A stratiˆed analysis by menopausal status showed a tendency that the eŠects of the REV1 SNPs are diŠerent between the pre-and post-menopausal women, if the signiˆcance level of p＝0.1 was employed for the exploratory heterogeneity analyses between the subgroups (Table 4) .
Discussion
Unlike DNA Pol h, which is relatively well-investigated for its role in error-free bypass of UV-induced DNA damage, little is known about how the other polymerases (Pol i, Pol k, REV1, and Pol z) involved in TLS aŠect susceptibility to cancer. This study investigated possible association betweenˆve polymorphisms in REV1 gene and breast cancer risk among Thai women.
Our results revealed that at least one of the REV1 SNPs (rs3087395) was associated with breast cancer risk. To our knowledge, the association between REV1 gene polymorphisms and breast cancer has not been examined previously. Moreover, the risk seems to diŠer between the pre-and postmenopausal breast cancer cases. It is plausible that factors interacting with this polymorphism in determining breast cancer risk also have a diŠerent role in pre-vs. postmenopausal cancers (16) . Since the observed eŠect is likely due to the interaction of the genetic variant with endogenous or exogenous risk factors (e.g., ionizing radiation), one might expect an eŠect modiˆcation by menopausal status. The propensity and mutagenicity of TLS have attracted a number of investigations on the etiology of most environmentally-induced cancers over the past decade. The TLS polymerases have been studied extensively in vitro (17) , but the in vivo role is only recently being investigated using knockout mouse models of carcinogenesis (18) . To date, limited epidemiological studies have been conducted to associate REV1 SNPs with cancer risk in humans. There are 16 SNPs in humans that result in nonsynonymous amino acid changes. Two nonsynonymous missense SNPs Phe257Ser (rs3087386) and Asn373Ser (rs3087399) in the coding region were studied. Recently, He et al. (19) found that Phe257Ser and Ser257Ser genotype of REV1 gene were associated with a decreased risk for cervical carcinoma, while Asn373Ser variant genotype was associated with an increased risk of cervical cancer. Another study by Sakiyama et al. (20) has explored the eŠect of REV1 polymorphisms on risk for lung cancer. They found that the REV1 Phe257Ser polymorphism was associated with an increased risk for squamous cell carcinoma. However, the Asn373Ser polymorphisms were not associated with an increased risk of lung cancer. Furthermore, the data from Dumstorf et al. (21) supported that lowering the level of REV1 in mouse cells will after the mutagenic response after exposure to carcinogens such as benzo[a]pyrene. In Fanconi Anemia (FA), a syndrome characterized by congenital abnormalities, progression bone marrow failure, and elevated cancer susceptibility, REV1 is required to prevent DNA crosslinker-induced chromosome aberrations in human cells (22) . Although the functional consequences of REV1 SNPs are unknown, published data and our data support a role of REV1 in the formation of multiple internal cancers.
In conclusion, our study has provided a piece of new evidence that REV1 polymorphisms are associated with an increased risk of breast cancer. This information may help elucidate TLS pathways through which variations in these SNPs may in‰uence breast cancer susceptibility, which deserves further epidemiological and functional validations.
